| Literature DB >> 23204864 |
M Gabrielle Pagé1, Jennifer Stinson, Fiona Campbell, Lisa Isaac, Joel Katz.
Abstract
BACKGROUND: Post-surgical pain is prevalent in children, yet is significantly understudied. The goals of this study were to examine gender differences in pain outcomes and pain-related psychological constructs postoperatively and to identify pain-related psychological correlates of acute post-surgical pain (APSP) and predictors of functional disability 2 weeks after hospital discharge.Entities:
Keywords: acute post-surgical pain; adolescents; children; pain anxiety; pain catastrophizing
Year: 2012 PMID: 23204864 PMCID: PMC3508661 DOI: 10.2147/JPR.S36614
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Recruitment process
| Total number of eligible participants | 534 |
| Reason not recruited | |
| No research staff available | 95 |
| Developmental/cognitive delays | 78 |
| Discharged | 71 |
| Parent absent | 40 |
| Noncommunicative | 31 |
| Sleeping | 22 |
| Pediatric intensive care unit | 21 |
| Parents not fluent in English | 19 |
| Undergoing other medical procedures | 6 |
| Other | 3 |
| Total number of potential participants approached | 148 |
| Reason for refusal to participate | |
| Not interested | 18 |
| Too tired | 16 |
| Too nauseous | 12 |
| Parents too busy | 5 |
| Already in other studies | 4 |
| Too much pain | 3 |
| Too sleepy | 3 |
| Other | 4 |
| Total number of participants | 83 |
| Lost to follow-up | 14 |
| Total number of completed follow-up 2 weeks after discharge | 69 |
Peri-operative Information
| SURGERY | Mean (SD) |
|---|---|
| Surgery Time (minutes) | 317.5 (141.3) |
| Intraoperative Opioids | n (%) |
| Fentanyl + Remifentanil + Morphine | 20 (24.0) |
| Fentanyl + Morphine | 23 (27.7) |
| Remifentanil + Morphine | 12 (14.5) |
| Fentanyl | 11 (13.2) |
| Fentanyl + Other | 7 (8.4) |
| Fentanyl + Remifentanil | 3 (3.6) |
| Morphine | 2 (2.5) |
| Other | 2 (2.5) |
| Remifentanil | 1 (1.2) |
| Intraoperative opioid data not available | 2 (2.5) |
|
| |
| Time in PACU | 181.2 (143.3) |
| PACU analgesics | n (%) |
| Morphine | 28 (33.8) |
| Acetaminophen + Morphine | 26 (31.4) |
| Acetaminophen + Fentanyl | 5 (6.0) |
| Acetaminophen + Other | 5 (6.0) |
| Acetaminophen + Hydromorphone | 5 (6.0) |
| Other | 4 (4.8) |
| Hydromorphone | 2 (2.4) |
| Fentanyl | 2 (2.4) |
| Acetaminophen + NSAID + Morphine | 1 (1.2) |
| Acetaminophen + NSAID | 1 (1.2) |
| Acetaminophen | 1 (1.2) |
| PACU analgesic data not available | 3 (3.6) |
|
| |
| Acetaminophen and NSAIDs | n (%) |
| Acetaminophen PO | 50 (60.2) |
| Acetaminophen PR | 13 (15.7) |
| Acetaminophen PO +NSAID IV | 9 (10.8) |
| Acetaminophen PO +NSAID PO | 2 (2.5) |
| Acetaminophen PR+NSAID IV | 1 (1.2) |
| Acetaminophen PR+NSAID PO | 1 (1.2) |
| NSAID PO | 1 (1.2) |
| Day 1 analgesic consumption not available | 6 (7.2) |
| Opioids | n (%) |
| Morphine IV | 50 (60.2) |
| Hydromorphone IV | 12 (14.5) |
| Fentanyl IV | 6 (7.2) |
| Morphine IV + Hydromorphone IV | 1 (1.2) |
| Morphine IV + Other | 1 (1.2) |
| Morphine PO + Fentanyl IV | 1 (1.2) |
| Other | 3 (3.6) |
| Day 1 analgesic consumption not available | 9 (10.9) |
| Mean (SD) | |
| Least Pain Score (NRS) | 1.50 (1.6) |
| Highest Pain Score (NRS) | 4.81 (2.5) |
Abbreviation: NRS, Numerical Rating Scale; NSAID, nonsteroidal anti-inflammatory drug; PACU, post anesthesia care unit; PO, orally; PR, per rectum; IV, intravenously; SD, standard deviation.
Mean (standard deviation) of pain and related psychological variables for boys, girls, and the total sample when measured 48–72 hours after surgery and 2 weeks after discharge
| 48–72 hours after surgery (0) | Two weeks after discharge (2) | |||||
|---|---|---|---|---|---|---|
|
|
| |||||
| Boys | Girls | Total | Boys | Girls | Total | |
| Pain anxiety (CPASS) | 46.11 (18.9) | 48.09 (19.5) | 47.45 (19.2) | 35.23 (16.4) | 38.77 (19.4) | 37.64 (18.4) |
| Pain catastrophizing (PCSC) | 21.69 (12.7) | 21.91 (12.1) | 21.84 (12.2) | |||
| Anxiety sensitivity (CASI) | 30.00 (6.0) | 34.32 (7.6) | 32.92 (7.4) | |||
| Depression (CES-DC) | 22.70 (10.4) | 23.55 (12.4) | 23.27 (11.7) | |||
| Anxiety (MASC-10) | 9.54 (4.9) | 12.84 (5.2) | 11.74 (5.3) | |||
| Pain | Yes = 23 | Yes = 53 | Yes = 76 | Yes = 14 | Yes = 38 | Yes = 52 |
| No = 4 | No = 3 | No = 7 | No = 8 | No = 9 | No = 17 | |
| Pain intensity (NRSI) | 3.44 (2.4) | 4.06 (2.3) | 3.86 (2.3) | 2.20 (2.1) | 2.32 (2.2) | 2.28 (2.2) |
| Pain unpleasantness (NRSU) | 3.70 (2.6) | 4.98 (2.8) | 4.57 (2.8) | 2.23 (2.3) | 2.73 (2.7) | 2.57 (2.6) |
| Functional disability (FDI) | 16.32 (9.4) | 21.15 (8.0) | 19.61 (8.8) | |||
Notes:
Pain intensity, pain unpleasantness, and functional disability scores are computed only for children who reported experiencing pain and do not take into account children who did not endorse pain at each time point.
Signficant difference between boys and girls (P < 0.05).
Abbreviations: CPASS, Child Pain Anxiety Symptoms Scale; PCSC, Pain Catastrophizing Scale-Children; CASI, Childhood Anxiety Sensitivity Index; CES-DC, Center for Epidemiological Studies-Depression Scale for Children; MASC-10, Multidimensional Anxiety Scale for Children-10; NRSI, Numerical Rating Scale for Pain Intensity; NRSU, Numerical Rating Scale for Pain Unpleasantness; FDI, Functional Disability Inventory.
Pain-related psychological variables (48–72 hours after surgery) associated with APSP (48–72 hours after surgery) intensity and unpleasantness using linear regression analysis
| β | t | F | df | Adj R2 | R2 change | ||
|---|---|---|---|---|---|---|---|
| Step 1 | 0.270 | 1.35 | 3;52 | 0.02 | 0.07 | ||
| Age | 0.25 | 1.85 | 0.069 | ||||
| Gender | −0.03 | −0.24 | 0.809 | ||||
| Morphine equivalent | −0.11 | −0.82 | 0.413 | ||||
| Step 2 | 0.006 | 3.73 | 5;50 | 0.20 | 0.20 | ||
| Age | 0.34 | 2.71 | 0.009 | ||||
| Gender | −0.06 | −0.45 | 0.654 | ||||
| Morphine equivalent | −0.10 | −0.82 | 0.419 | ||||
| CES-DC | 0.56 | 3.42 | 0.001 | ||||
| MASC-10 | −0.19 | −1.11 | 0.273 | ||||
| Step 3 | 0.001 | 5.97 | 6;49 | 0.35 | 0.15 | ||
| Age | 0.26 | 2.24 | 0.030 | ||||
| Gender | −0.09 | −0.72 | 0.473 | ||||
| Morphine equivalent | −0.11 | −0.95 | 0.349 | ||||
| CES-DC | 0.36 | 2.31 | 0.025 | ||||
| MASC-10 | −0.38 | −2.28 | 0.027 | ||||
| CPASS | 0.51 | 3.58 | 0.001 | ||||
| Step 1 | 0.109 | 2.11 | 3;55 | 0.05 | 0.10 | ||
| Age | 0.10 | 0.75 | 0.457 | ||||
| Gender | −0.22 | −1.72 | 0.092 | ||||
| Morphine equivalent | −0.26 | −1.96 | 0.056 | ||||
| Step 2 | 0.034 | 2.62 | 5;53 | 0.12 | 0.10 | ||
| Age | 0.16 | 1.26 | 0.275 | ||||
| Gender | −0.24 | −1.78 | 0.081 | ||||
| Morphine equivalent | −0.25 | −1.86 | 0.068 | ||||
| CES-DC | 0.38 | 2.29 | 0.026 | ||||
| MASC-10 | −0.12 | −0.67 | 0.508 | ||||
| Step 3 | 0.012 | 3.05 | 6;52 | 0.18 | 0.06 | ||
| Age | 0.16 | 1.22 | 0.226 | ||||
| Gender | −0.25 | −1.97 | 0.054 | ||||
| Morphine equivalent | −0.27 | −2.08 | 0.042 | ||||
| CES-DC | 0.26 | 1.55 | 0.127 | ||||
| MASC-10 | −0.22 | −1.25 | 0.216 | ||||
| PCSC | 0.32 | 2.09 | 0.042 | ||||
Abbreviations: Adj, adjusted; APSP, acute post-surgical pain; CPASS, Child Pain Anxiety Symptoms Scale; PCSC, Pain Catastrophizing Scale-Children; CESD-C, Center for Epidemiological Studies-Depression Scale for Children; MASC-10, Multidimensional Anxiety Scale for Children-10.
Pain-related psychological variables (48–72 hours after surgery) associated with APSP (2 weeks after discharge) intensity and unpleasantness and functional disability using linear regression analysis
| β | t | F | df | Adj R2 | R2 change | ||
|---|---|---|---|---|---|---|---|
| Step 1 | 0.261 | 1.38 | 3;45 | 0.02 | 0.08 | ||
| Age | 0.18 | 1.25 | 0.219 | ||||
| Gender | 0.23 | 1.55 | 0.127 | ||||
| Morphine equivalent | −0.13 | −0.91 | 0.367 | ||||
| Step 2 | 0.105 | 1.95 | 5;43 | 0.09 | 0.10 | ||
| Age | 0.24 | 1.62 | 0.112 | ||||
| Gender | 0.20 | 1.38 | 0.174 | ||||
| Morphine equivalent | −0.12 | −0.79 | 0.433 | ||||
| CES-DC | 0.42 | 2.15 | 0.037 | ||||
| MASC-10 | −0.17 | −0.85 | 0.400 | ||||
| Step 3 | |||||||
| Age | No variables entered using stepwise method | ||||||
| Gender | |||||||
| CES-DC | |||||||
| MASC-10 | |||||||
| Step 1 | 0.436 | 0.93 | 3;45 | −0.01 | 0.06 | ||
| Age | 0.10 | 0.70 | 0.491 | ||||
| Gender | 0.75 | 0.51 | 0.611 | ||||
| Morphine equivalent | −0.23 | −1.52 | 0.135 | ||||
| Step 2 | 0.142 | 1.76 | 5;43 | 0.07 | 0.11 | ||
| Age | 0.17 | 1.18 | 0.245 | ||||
| Gender | 0.09 | 0.60 | 0.550 | ||||
| Morphine equivalent | −0.18 | −1.21 | 0.233 | ||||
| CES-DC | 0.35 | 1.76 | 0.085 | ||||
| MASC-10 | −0.01 | −0.01 | 0.994 | ||||
| Step 3 | |||||||
| Age | No variables entered using stepwise method | ||||||
| Gender | |||||||
| CES-DC | |||||||
| MASC-10 | |||||||
| Step 1 | 0.302 | 1.25 | 3;45 | 0.08 | 0.08 | ||
| Age | −0.01 | −0.04 | 0.965 | ||||
| Gender | −0.16 | −1.08 | 0.285 | ||||
| Morphine equivalent | −0.24 | −1.66 | 0.104 | ||||
| Step 2 | 0.002* | 4.53 | 5;43 | 0.35 | 0.27 | ||
| Age | 0.10 | 0.76 | 0.453 | ||||
| Gender | −0.14 | −1.10 | 0.277 | ||||
| Morphine equivalent | −0.18 | −1.34 | 0.188 | ||||
| CES-DC | 0.56 | 3.21 | 0.002 | ||||
| MASC-10 | −0.04 | −0.23 | 0.823 | ||||
| Step 3 | 0.001* | 5.32 | 6;42 | 0.43 | 0.09 | ||
| Age | 0.04 | 0.31 | 0.758 | ||||
| Gender | −0.15 | −1.18 | 0.246 | ||||
| Morphine equivalent | −0.19 | −1.53 | 0.133 | ||||
| CES-DC | 0.42 | 2.42 | 0.020 | ||||
| MASC-10 | −0.18 | −1.01 | 0.319 | ||||
| CPASS | 0.39 | 2.54 | 0.015 | ||||
Note: P < 0.05
Abbreviations: Adj, adjusted; APSP, acute post-surgical pain; CPASS, Child Pain Anxiety Symptoms Scale; PCSC, Pain Catastrophizing Scale-Children; CESD-C, Center for Epidemiological Studies-Depression Scale for Children; MASC-10, Multidimensional Anxiety Scale for Children-10.
Figure 1Summary of results showing that children who were surgery-naïve had higher levels of anxiety sensitivity and general anxiety compared with children who had undergone surgery in the past.
Notes: Girls reported higher levels of anxiety sensitivity, general anxiety, and pain unpleasantness 48–72 hours after surgery, as well as functional disability 2 weeks after discharge compared with boys. Age, depression, general anxiety, and pain anxiety scores were significantly associated with pain intensity, while analgesic consumption and pain catastrophizing were significantly associated with pain unpleasantness 48–72 hours after surgery. Levels of pain anxiety 48–72 hours after surgery predicted levels of functional disability 2 weeks after discharge from hospital. Plain one-sided arrows represent predictors of pain outcomes. Long-dashed, double-sided arrows represent correlates of pain outcomes. Short-dashed arrows represent predictors of changes in pain and functional disability over time. Black boxes represent pain and functional disability outcomes. Gray boxes represent predictors and correlates.